Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dowsett

Showing results (171-180 of 304) with videos related to

Pageof 31
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2006
Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 statusM Dowsett, J Houghton, C Iden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patientsJ Geisler, N King, G Anker, et al.
Lancet (London, England)|January 19, 1985
Low-dose aminoglutethimide and aromatase inhibitionM Dowsett, S L Jeffcoate, S Santner, et al.
British Journal of Cancer|October 1, 1990
The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancerR C Stein, M Dowsett, A Hedley, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1993
Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal womenT J Iveson, I E Smith, J Ahern, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1982
Endocrine and therapeutic effects of aminoglutethimide in premenopausal patients with breast cancerA L Harris, M Dowsett, S L Jeffcoate, et al.
Analytical Chemistry|December 15, 2006
Chemical and morphological changes of historical lead objects as a result of the use of electrolytic reduction as a stabilization treatmentB Schotte, A Adriaens, F Dhooghe, et al.
The Pharmacogenomics Journal|June 16, 2010
High-efficiency genotype analysis from formalin-fixed, paraffin-embedded tumor tissuesM J Sikora, J N Thibert, J Salter, et al.
Steroids|July 1, 1987
4-Hydroxyandrostenedione treatment for postmenopausal patients with advanced breast cancerR C Coombes, P E Goss, M Dowsett, et al.
British Journal of Cancer|January 1, 1997
The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistanceS R Johnston, S Riddler, B P Haynes, et al.
Pageof 31

Showing results (171-180 of 304) with videos related to

Sort By:
Pageof 31
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2006
Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 statusM Dowsett, J Houghton, C Iden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patientsJ Geisler, N King, G Anker, et al.
Lancet (London, England)|January 19, 1985
Low-dose aminoglutethimide and aromatase inhibitionM Dowsett, S L Jeffcoate, S Santner, et al.
British Journal of Cancer|October 1, 1990
The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancerR C Stein, M Dowsett, A Hedley, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1993
Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal womenT J Iveson, I E Smith, J Ahern, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1982
Endocrine and therapeutic effects of aminoglutethimide in premenopausal patients with breast cancerA L Harris, M Dowsett, S L Jeffcoate, et al.
Analytical Chemistry|December 15, 2006
Chemical and morphological changes of historical lead objects as a result of the use of electrolytic reduction as a stabilization treatmentB Schotte, A Adriaens, F Dhooghe, et al.
The Pharmacogenomics Journal|June 16, 2010
High-efficiency genotype analysis from formalin-fixed, paraffin-embedded tumor tissuesM J Sikora, J N Thibert, J Salter, et al.
Steroids|July 1, 1987
4-Hydroxyandrostenedione treatment for postmenopausal patients with advanced breast cancerR C Coombes, P E Goss, M Dowsett, et al.
British Journal of Cancer|January 1, 1997
The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistanceS R Johnston, S Riddler, B P Haynes, et al.
Pageof 31